Paeds SAQs · genetics-dysmorphology-and-metabolism
Prader-Willi and Angelman syndromes — formative SAQs
Formative SAQs on recognising Prader-Willi syndrome in the neonate, recognising Angelman syndrome in the toddler, confirming the molecular diagnosis with methylation analysis, determining the molecular subtype for recurrence-risk counselling, and building syndrome-specific multidisciplinary management.
On this page
Study tools
Target exams
SAQ 1 (10 marks)
A two-week-old neonate is referred for profound hypotonia, poor feeding, and a weak cry. Birth weight was at the 10th centile. He requires nasogastric feeding. Examination reveals a narrow bifrontal diameter, almond-shaped palpebral fissures, a thin upper lip, bilateral cryptorchidism, and acromicria. A standard karyotype has been reported as normal. [1] [3]
a) Give the most likely diagnosis and explain why a normal karyotype does not exclude it. Name the first-tier molecular test you will order. (3 marks) [1] [4]
b) Describe the three molecular subtypes of this syndrome, their approximate relative frequencies, and the mechanism by which each produces the phenotype. (3 marks) [3] [4]
c) Outline the syndrome-specific management plan for this child across infancy and childhood, naming four domains that require active intervention. (2 marks) [1] [7]
d) Explain why molecular subtype determination is essential for genetic counselling, and state the recurrence risk for each subtype. (2 marks) [4]
References7ShowHide
- [1]Driscoll DJ, Miller JL, Cassidy SB Prader-Willi Syndrome. GeneReviews, 1993.PMID 20301505
- [2]Dagli AI, Mathews J, Williams CA Angelman Syndrome. GeneReviews, 1993.PMID 20301323
- [3]Cassidy SB. Prader-Willi and Angelman syndromes. Disorders of genomic imprinting. Medicine, 1998.PMID 9556704
- [4]Beygo J, et al. Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes. Eur J Hum Genet, 2019.PMID 31235867
- [6]Duis J, et al. A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome. Mol Genet Genomic Med, 2022.PMID 35150089
- [7]Koch L. Consensus guidelines for GH therapy in Prader-Willi syndrome. Nat Rev Endocrinol, 2013.PMID 23609333
- [9]Manssen L, Krey I, Gburek-Augustat J, et al. Precision Medicine in Angelman Syndrome. Neuropediatrics, 2025.PMID 39168152